Datum: 31.8.2015
Summary: | |
A university spin-off SME in northern Sweden offers a new pre-clinical model for testing new anti-fibrotic and anti-inflammatory drugs. The new model shortens and simplifies the tests, lowering the cost and performs considerably better than the ones existing today. The SME is looking for partners that develop anti-fibrotic drugs or anti-inflammatory drugs, enabling them to do the testing more efficiently. The SME offers licensing of the entire concept and/or delivering test services. | |
Reference: | TOSE20150427001 |
Country: | Sweden |
Submitted: | Apr 27 2015 |
Updated: | Jul 10 2015 |
View Partnering Opportunity | |
KEYWORDS | |
Market: | Cellular and Molecular Biology, Genetic Engineering , Molecular design , Other Genetic Engineering |
Technology: | Clinical Research, Trials, Genetic Engineering |
NACE: | Research and experimental development on biotechnology |
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2025 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
Plant Biotechnology - plant biotechnology
Věda - Dějiny vědy, historie vědy na Wikipedii
Proti nádorům by mohla zasahovat bakteriální léčba
Novou vakcínu proti rakovině plic dostal první pacient